Structures by: Yathirajan H. S.
Total: 746
Tramadolium picrate
C16H26NO2,C6H2N3O7
Acta Crystallographica Section E (2012) 68, 3 o600
a=8.5674(10)Å b=12.3664(12)Å c=13.2276(13)Å
α=113.003(9)° β=107.686(10)° γ=95.541(9)°
4-[Bis(4-fluorophenyl)methyl]piperazin-1-ium bis(trichloroacetate) 0.4-hydrate
C17H20F2N22,2(C2Cl3O2),0.4(H2O)
Acta Crystallographica Section E (2012) 68, 4 o968
a=8.8101(7)Å b=33.555(3)Å c=9.4453(7)Å
α=90.00° β=108.723(2)° γ=90.00°
4-Methylphenyl quinoline-2-carboxylate
C17H13NO2
Acta Crystallographica Section E (2012) 68, 11 o3231-o3232
a=11.5421(2)Å b=17.3191(3)Å c=26.6667(5)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 2-amino-6-(4-bromophenyl)-4-(4-fluorophenyl)cyclohexa-1,3-diene-1-carboxylate
C21H19BrFNO2
Acta Crystallographica Section E (2013) 69, 9 o1473
a=9.4599(2)Å b=23.3634(5)Å c=17.2312(4)Å
α=90° β=96.001(2)° γ=90°
3-Amino-1<i>H</i>-pyrazol-2-ium trifluoroacetate
C3H6N3,C2F3O2
Acta Crystallographica Section E (2013) 69, 9 o1425-o1426
a=10.9292(8)Å b=10.9332(6)Å c=13.7002(13)Å
α=90° β=107.939(9)° γ=90°
4-Hydroxy-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-6(5<i>H</i>)-one dihydrate
C15H12N4O4,2(H2O)
Acta Crystallographica Section E (2013) 69, 11 o1707-o1708
a=9.5817(3)Å b=13.9439(3)Å c=12.4804(4)Å
α=90° β=109.832(3)° γ=90°
Bis-[1-(benzo[1,3]dioxol-5-yl-methyl)piperazinyl]methane
C25H32N4O4
Acta Crystallographica Section E (2013) 69, 11 o1669
a=38.8025(10)Å b=9.7675(2)Å c=6.09571(13)Å
α=90° β=90° γ=90°
<i>N</i>-(1,3-Benzothiazol-2-yl)acetamide
C9H8N2OS
Acta Crystallographica Section E (2013) 69, 11 o1622
a=11.1852(4)Å b=7.4037(4)Å c=20.9189(8)Å
α=90° β=94.408(3)° γ=90°
2-[4-(Trifluoromethyl)phenylsulfanyl]benzoic acid
C14H9F3O2S
Acta Crystallographica Section E (2013) 69, 11 o1704
a=7.3071(5)Å b=8.0790(7)Å c=11.3878(11)Å
α=82.678(8)° β=83.642(7)° γ=72.309(7)°
<i>N</i>-(1<i>H</i>-Indol-3-ylmethylidene)-4-methylpiperazin-1-amine
C14H18N4
Acta Crystallographica Section E (2013) 69, 11 o1706
a=7.5630(5)Å b=6.5593(4)Å c=13.2319(9)Å
α=90° β=100.072(6)° γ=90°
1-[4-(4-Hydroxyphenyl)piperazin-1-yl]ethanone
C12H16N2O2
Acta Crystallographica Section E (2013) 69, 11 o1671
a=6.13183(19)Å b=12.0106(4)Å c=14.8704(5)Å
α=90° β=94.025(3)° γ=90°
Raltegravir monohydrate
C20H21FN6O5,H2O
Acta Crystallographica Section E (2013) 69, 12 o1743-o1744
a=8.3860(6)Å b=11.8610(9)Å c=12.1102(9)Å
α=110.481(7)° β=108.093(7)° γ=92.329(6)°
1-Piperonylpiperazinium picrate
C12H17N2O2,C6H2N3O7
Acta Crystallographica Section E (2014) 70, 2 o208-o209
a=12.0864(2)Å b=6.96981(11)Å c=23.4898(4)Å
α=90° β=96.5141(17)° γ=90°
(<i>E</i>)-1-(2,4-Dinitrophenyl)-2-(2-fluorobenzylidene)hydrazine
C13H9FN4O4
Acta Crystallographica Section E (2011) 67, 5 o1200-o1201
a=7.0961(8)Å b=8.2714(9)Å c=11.7230(8)Å
α=88.614(7)° β=80.544(8)° γ=71.368(10)°
2,4-Bis(4-fluorophenyl)-2,3-dihydro-1<i>H</i>-1,5-benzodiazepine
C21H16F2N2
Acta Crystallographica Section E (2011) 67, 5 o1262-o1263
a=12.9151(4)Å b=6.0438(3)Å c=21.2851(7)Å
α=90° β=92.147(3)° γ=90°
(6<i>Z</i>)-3,5-Bis(4-fluorophenyl)-6-(1-hydroxyethylidene)cyclohex-2-en-1-one
C20H16F2O2
Acta Crystallographica Section E (2012) 68, 3 o638-o639
a=17.663(2)Å b=6.2371(6)Å c=15.2357(16)Å
α=90.00° β=107.717(13)° γ=90.00°
(<i>E</i>)-1-(4,4''-Difluoro-5'-methoxy-1,1':3',1''-terphenyl-4'-yl)-3-(4-methylphenyl)prop-2-en-1-one
C29H22F2O2
Acta Crystallographica Section E (2011) 67, 12 o3181-o3182
a=6.9020(3)Å b=11.3965(6)Å c=14.8362(8)Å
α=96.177(2)° β=93.381(2)° γ=106.446(2)°
(<i>E</i>)-1-(4,4''-Difluoro-5'-methoxy-1,1':3',1''-terphenyl-4'-yl)-3-(4-nitrophenyl)prop-2-en-1-one
C28H19F2NO4
Acta Crystallographica Section E (2011) 67, 12 o3179-o3180
a=23.3751(7)Å b=6.9098(2)Å c=13.7879(5)Å
α=90.00° β=99.243(2)° γ=90.00°
3-(4-Fluorophenyl)-1<i>H</i>-pyrazole--5-(4-fluorophenyl)-1<i>H</i>-pyrazole (1/1)
C9H7FN2
Acta Crystallographica Section E (2014) 70, 9 o949-o950
a=10.3961(5)Å b=10.8565(6)Å c=16.1431(7)Å
α=84.704(4)° β=76.223(4)° γ=68.249(5)°
<i>N</i>-(3-Benzoyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)benzamide
C22H19NO2S
Acta Crystallographica Section E (2014) 70, 9 o951-o952
a=13.5223(4)Å b=6.23222(15)Å c=22.2941(6)Å
α=90° β=106.150(3)° γ=90°
Opipramolium fumarate
C23H30N3O,C4H3O4
Acta Crystallographica Section E (2011) 67, 9 o2296
a=8.9116(3)Å b=6.7167(3)Å c=20.6377(8)Å
α=90.00° β=98.685(3)° γ=90.00°
9,9-Dimethyl-9,10-dihydroanthracene
C16H16
Acta Crystallographica Section E (2011) 67, 9 o2397
a=12.7042(15)Å b=7.4882(7)Å c=13.177(2)Å
α=90.00° β=107.787(14)° γ=90.00°
5-(Biphenyl-4-yl)-3-(3-methoxybenzylidene)furan-2(3<i>H</i>)-one
C24H18O3
Acta Crystallographica Section E (2011) 67, 9 o2294-o2295
a=19.8766(8)Å b=6.9914(3)Å c=13.2603(6)Å
α=90.00° β=107.735(4)° γ=90.00°
Methyl 3,5-dibromo-2-diacetylaminobenzoate
C12H11Br2NO4
Acta Crystallographica Section E (2011) 67, 9 o2503
a=7.6386(8)Å b=8.8870(6)Å c=10.8691(8)Å
α=78.186(6)° β=76.155(7)° γ=82.750(7)°
Tramadol hydrochloride-Benzoic acid (1/1)
C16H26NO2,Cl,C7H6O2
Acta Crystallographica Section E (2011) 67, 9 o2351
a=8.9721(2)Å b=10.4086(2)Å c=12.5189(3)Å
α=90.00° β=101.646(2)° γ=90.00°
4-[(4-Benzyloxybenzylidene)amino]-1,5-dimethyl-2-phenyl- 1<i>H</i>-pyrazol-3(2<i>H</i>)-one
C25H23N3O2
Acta Crystallographica Section E (2012) 68, 5 o1324
a=19.8137(19)Å b=6.1588(4)Å c=18.0784(14)Å
α=90.00° β=108.881(9)° γ=90.00°
4-[(1<i>E</i>)-3-(2,6-Dichloro-3-fluorophenyl)-3-oxoprop-1-en-1-yl]benzonitrile
C16H8Cl2FNO
Acta Crystallographica Section E (2012) 68, 5 o1413
a=13.2751(3)Å b=8.5002(2)Å c=13.9854(3)Å
α=90.00° β=116.7730(10)° γ=90.00°
Flupentixol tartrate
C23H26F3N2OS,C4H5O6
Acta Crystallographica Section E (2014) 70, 2 o206-o207
a=9.9239(3)Å b=9.1968(3)Å c=30.0099(8)Å
α=90° β=96.617(3)° γ=90°
5-Aminopyrazol-2-ium hydrogen succinate
C3H6N3,C4H5O4
Acta Crystallographica Section E (2014) 70, 2 o221-o222
a=18.525(3)Å b=6.7872(9)Å c=14.564(3)Å
α=90° β=108.900(18)° γ=90°
Enrofloxacinium oxalate
2(C19H23FN3O3),C2O42
Acta Crystallographica Section E (2014) 70, 2 o200-o201
a=9.8552(5)Å b=13.3056(8)Å c=15.6124(8)Å
α=68.987(5)° β=84.740(4)° γ=73.093(5)°
[2-(1-Hydroxycyclohexyl)-2-(4-hydroxyphenyl)ethyl]dimethylammonium chloranilate ethyl acetate
C16H26NO2,C6HCl2O4,C4H8O2
Acta Crystallographica Section E (2013) 69, 10 o1556-o1557
a=11.1738(2)Å b=9.39846(16)Å c=13.6046(2)Å
α=90.00° β=105.109(2)° γ=90.00°
3-(1<i>H</i>-Imidazol-1-yl)propanaminium picrate
C6H2N3O7,C6H12N3
Acta Crystallographica Section E (2013) 69, 10 o1572-o1573
a=11.98275(18)Å b=38.5234(6)Å c=16.4239(2)Å
α=90° β=94.1970(14)° γ=90°
(1<i>E</i>,4<i>E</i>)-1-(3-Nitrophenyl)-5-phenylpenta-1,4-dien-3-one
C17H13NO3
Acta Crystallographica Section E (2012) 68, 1 o74-o75
a=11.9806(6)Å b=9.8955(4)Å c=12.5562(7)Å
α=90° β=114.992(7)° γ=90°
(2<i>E</i>)-2-[(3<i>E</i>)-4-Phenylbut-3-en-2-ylidene]hydrazinecarboxamide
C11H13N3O
Acta Crystallographica Section E (2012) 68, 1 o76-o77
a=15.1094(8)Å b=24.4445(11)Å c=7.0368(4)Å
α=90° β=109.908(6)° γ=90°
1-[Amino(4-chlorophenyl)methyl]-6-bromonaphthalen-2-ol
C17H13BrClNO
Acta Crystallographica Section E (2012) 68, 2 o535
a=4.8026(15)Å b=10.785(3)Å c=15.086(4)Å
α=67.64(2)° β=79.43(2)° γ=85.32(2)°
2-(2,4-Dichlorophenyl)-<i>N</i>-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro- 1<i>H</i>-pyrazol-4-yl)acetamide
C19H17Cl2N3O2
Acta Crystallographica Section E (2013) 69, 1 o39
a=25.1853(5)Å b=8.18108(9)Å c=21.0978(4)Å
α=90.00° β=119.772(3)° γ=90.00°
4-(4-Iodoanilino)-2-methylene-4-oxobutanoic acid
C11H10INO3
Acta Crystallographica Section E (2013) 69, 1 o83
a=23.1111(6)Å b=4.78630(10)Å c=10.4262(2)Å
α=90.00° β=97.0710(10)° γ=90.00°
2-(2,6-Dichlorophenyl)-<i>N</i>-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro- 1<i>H</i>-pyrazol-4-yl)acetamide
C19H17Cl2N3O2
Acta Crystallographica Section E (2013) 69, 1 o46-o47
a=20.3442(11)Å b=12.1080(8)Å c=14.9500(8)Å
α=90.00° β=93.837(5)° γ=90.00°
6-(3-Chlorophenyl)imidazo[2,1-<i>b</i>][1,3,4]thiadiazole
C10H6ClN3S
Acta Crystallographica Section E (2013) 69, 1 o66
a=5.43804(19)Å b=12.4222(4)Å c=14.1684(4)Å
α=90.00° β=100.269(3)° γ=90.00°
Diphenylmethyl benzoate
C20H16O2
Acta Crystallographica Section E (2013) 69, 1 o81
a=5.75357(19)Å b=16.0368(5)Å c=8.3114(3)Å
α=90.0° β=95.340(3)° γ=90.0°
4-<i>tert</i>-butyl-<i>N</i>-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)- 2-(pyrimidin-2-yl)pyrimidin-4-yl]benzene-1-sulfonamide monohydrate
C27H29N5O6S,H2O
Acta Crystallographica Section E (2013) 69, 1 o12-o13
a=12.3393(4)Å b=15.1238(6)Å c=14.6988(4)Å
α=90.00° β=95.037(3)° γ=90.00°
4-Diphenylmethyl-1-[(<i>E</i>)-3-phenylprop-2-en-1-yl]piperazin-1-ium (2<i>Z</i>)-3-carboxyprop-2-enoate
C26H29N2,C4H3O4
Acta Crystallographica Section E (2013) 69, 1 o142-o143
a=21.9467(4)Å b=10.43729(18)Å c=11.20623(19)Å
α=90.00° β=90.0458(15)° γ=90.00°
3-Chloro-4-fluoroanilinium picrate
C6H6ClF,C6H2N3O7
Acta Crystallographica Section E (2013) 69, 2 o240
a=4.4054(2)Å b=11.9881(5)Å c=13.7010(5)Å
α=90.0570(10)° β=91.8030(10)° γ=97.7430(10)°
2-Methyl-4-(4-methylpiperazin-4-ium-1-yl)-10<i>H</i>- thieno[2,3-<i>b</i>][1,5]benzodiazepinium bis(2,4,6-trinitrophenolate)
C17H22N4S2,2(C6H2N3O7)
Acta Crystallographica Section E (2013) 69, 2 o232-o233
a=22.1660(4)Å b=12.7349(2)Å c=23.3951(4)Å
α=90.00° β=90.00° γ=90.00°
{2-[(4-Nitrobenzylidene)amino]-4,5,6,7-tetrahydro-1-benzothiophen-3-yl}(phenyl)methanone
C22H18N2O3S
Acta Crystallographica Section E (2014) 70, 6 o738-o739
a=4.61595(13)Å b=17.6844(4)Å c=11.7068(3)Å
α=90° β=91.285(3)° γ=90°
4-acetylpiperazinium picrate
C6H13N2O,C6H2N3O7
Acta Crystallographica Section E (2014) 70, 6 o717-o718
a=6.6843(7)Å b=11.5971(12)Å c=20.131(2)Å
α=90° β=90.000(4)° γ=90°
4-(4-Chlorophenyl)-4-hydroxypiperidinium benzoate
C11H15ClNO,C7H5O2
Acta Crystallographica Section E (2011) 67, 6 o1436
a=9.6235(12)Å b=10.0971(16)Å c=10.2251(14)Å
α=99.608(12)° β=108.748(13)° γ=113.357(14)°
4,6-Bis(4-fluorophenyl)-2-phenyl-1<i>H</i>-indazol-3(2<i>H</i>)-one
C25H16F2N2O
Acta Crystallographica Section E (2011) 67, 6 o1346-o1347
a=15.2947(4)Å b=11.6259(2)Å c=20.9388(5)Å
α=90° β=90° γ=90°
(1<i>E</i>,2<i>E</i>)-1,2-Bis(3-bromo-4-methoxybenzylidene)hydrazine
C16H14Br2N2O2
Acta Crystallographica Section E (2011) 67, 6 o1379
a=10.1354(8)Å b=10.5500(10)Å c=15.6055(12)Å
α=90.00° β=96.680(7)° γ=90.00°
3,5-Bis(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazole-1-carbaldehyde
C16H12F2N2O
Acta Crystallographica Section E (2011) 67, 6 o1292-o1293
a=6.2141(9)Å b=6.7802(8)Å c=17.9857(9)Å
α=96.727(4)° β=90.254(4)° γ=116.791(5)°
Opipramol
C23H29N3O
Acta Crystallographica Section E (2011) 67, 7 o1598
a=12.6215(2)Å b=10.5929(2)Å c=14.3629(2)Å
α=90.00° β=90.9660(10)° γ=90.00°
<i>N</i>-(3-Chloro-4-fluorophenyl)-2-(naphthalen-1-yl)acetamide
C18H13ClFNO
Acta Crystallographica Section E (2011) 67, 7 o1826
a=8.096(6)Å b=23.323(6)Å c=8.404(3)Å
α=90.00° β=110.83(5)° γ=90.00°
3-(5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>]cyclohepten-5-ylidene)- <i>N</i>,<i>N</i>-dimethylpropanaminium chloride
C20H22N,Cl
Acta Crystallographica Section E (2011) 67, 7 o1846
a=32.0959(7)Å b=32.0959(7)Å c=13.7578(5)Å
α=90.00° β=90.00° γ=90.00°
2-(4-Methylphenyl)benzonitrile
C14H11N
Acta Crystallographica Section E (2011) 67, 7 o1647
a=7.6726(4)Å b=11.4037(5)Å c=12.2426(5)Å
α=90.00° β=90.00° γ=90.00°
1-(5,5-Dioxido-10<i>H</i>-phenothiazin-10-yl)ethanone
C14H11NO3S
Acta Crystallographica Section E (2011) 67, 7 o1702
a=12.5715(6)Å b=8.7648(4)Å c=11.5828(5)Å
α=90.00° β=92.142(4)° γ=90.00°
3-(5,5-dioxophenothiazin-10-yl)-<i>N</i>,<i>N</i>,2-trimethylpropanaminium chloride
C18H23N2O2S,Cl
Acta Crystallographica Section E (2011) 67, 8 o1875
a=7.6364(7)Å b=10.4177(9)Å c=12.4732(10)Å
α=103.478(7)° β=90.624(7)° γ=109.852(8)°
Methyl 2-(4-hydroxybenzoyl)benzoate
C15H12O4
Acta Crystallographica Section E (2011) 67, 8 o1994
a=8.9017(12)Å b=13.9940(17)Å c=10.0473(12)Å
α=90.00° β=94.687(12)° γ=90.00°
3,5-Bis(4-methoxyphenyl)-4,5-dihydroisoxazole
C17H17NO3
Acta Crystallographica Section E (2011) 67, 8 o1975-o1976
a=10.5071(7)Å b=8.4023(5)Å c=32.6662(19)Å
α=90° β=90° γ=90°
2,2-Diphenylacetamide
C14H13NO
Acta Crystallographica Section E (2011) 67, 8 o1992-o1993
a=5.1687(3)Å b=28.5511(13)Å c=7.8006(4)Å
α=90.00° β=98.152(5)° γ=90.00°
1,3-Bis(4-fluorophenyl)-<i>N</i>,<i>N</i>'-(propane-1,3- diylidene)dihydroxylamine
C15H12F2N2O2
Acta Crystallographica Section E (2011) 67, 8 o1954-o1955
a=9.9233(7)Å b=10.4236(6)Å c=13.2422(11)Å
α=86.419(6)° β=79.205(7)° γ=89.932(5)°
4-(1<i>H</i>-Benzimidazol-2-ylmethoxy)-3-methoxybenzaldehyde tetrahydrate
C16H14N2O3,4(H2O)
Acta Crystallographica Section E (2011) 67, 8 o2021-o2022
a=6.8953(6)Å b=11.4266(13)Å c=11.7287(14)Å
α=107.965(10)° β=90.906(8)° γ=91.769(8)°
2-Chloro-<i>N</i>-[2-(2-fluorobenzoyl)-4-nitrophenyl]-<i>N</i>- methylacetamide
C16H12ClFN2O4
Acta Crystallographica Section E (2011) 67, 9 o2537-o2538
a=8.1339(6)Å b=10.9639(8)Å c=17.8690(11)Å
α=81.251(6)° β=82.239(6)° γ=87.937(6)°
<i>N</i>,<i>N</i>-Dimethyl-3-oxo-3-(thiophen-2-yl)propanaminium chloride
C9H14NOS,Cl
Acta Crystallographica Section E (2011) 67, 9 o2271
a=5.8663(3)Å b=27.0109(9)Å c=7.1385(4)Å
α=90.00° β=110.767(6)° γ=90.00°
2-[(<i>E</i>)-1-(4-methylphenyl)-3-(pyrrolidin-1-ium- 1-yl)prop-1-enyl]pyridinium bis(2,4,6-trinitrophenolate)
C19H24N22,2(C6H2N3O7)
Acta Crystallographica Section E (2011) 67, 9 o2502
a=15.0542(7)Å b=12.7489(5)Å c=17.1446(7)Å
α=90.00° β=100.218(4)° γ=90.00°
[3-(5-Hydroxy-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>]cyclohepten-5- yl)propyl]dimethylammonium 3-carboxyprop-2-enoate
C20H24NO,C4H3O4
Acta Crystallographica Section E (2011) 67, 10 o2600-o2601
a=9.2115(2)Å b=11.5840(2)Å c=10.4640(2)Å
α=90.00° β=101.591(2)° γ=90.00°
4-[Bis(4-fluorophenyl)methyl]piperazin-1-ium 2-(2-phenylethyl)benzoate
C17H19F2N2,C15H13O2
Acta Crystallographica Section E (2011) 67, 10 o2783-o2784
a=8.2330(2)Å b=35.5366(10)Å c=10.1505(3)Å
α=90.00° β=112.9250(10)° γ=90.00°
<i>N</i>-(4-Chloro-1,3-benzothiazol-2-yl)-2-(3-methylphenyl)acetamide monohydrate
C16H13ClN2OS,H2O
Acta Crystallographica Section E (2011) 67, 10 o2602-o2603
a=7.2771(3)Å b=9.2568(5)Å c=12.0851(5)Å
α=83.948(4)° β=84.306(3)° γ=72.133(4)°
4,4'-Difluorobenzhydryl piperazinium picrate
C17H19F2N2,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 10 o2587-o2588
a=8.9425(2)Å b=11.8286(2)Å c=23.0922(4)Å
α=90.00° β=105.7200(10)° γ=90.00°
<i>N</i>-(3-Chloro-4-fluorophenyl)-2,2-diphenylacetamide
C20H15ClFNO
Acta Crystallographica Section E (2011) 67, 10 o2604
a=9.3665(17)Å b=10.2069(12)Å c=9.7774(16)Å
α=90.00° β=114.42(2)° γ=90.00°
3-Chloroanilinium 4-methylbenzenesulfonate
C6H7ClN,C7H7O3S
Acta Crystallographica Section E (2011) 67, 11 o2925
a=12.7848(3)Å b=6.7767(2)Å c=16.1702(4)Å
α=90.00° β=105.081(2)° γ=90.00°
2-(2-Benzylphenyl)propan-2-ol
C16H18O
Acta Crystallographica Section E (2011) 67, 12 o3302
a=12.2252(3)Å b=17.2508(4)Å c=16.7784(3)Å
α=90.00° β=132.5490(10)° γ=90.00°
(<i>E</i>)-1-(4,4''-Difluoro-5'-methoxy-1,1':3',1''-terphenyl-4'-yl)-3-(4-methoxyphenyl)prop-2-en-1-one
C29H22F2O3
Acta Crystallographica Section E (2011) 67, 12 o3323-o3324
a=9.6059(2)Å b=19.2236(5)Å c=13.3772(3)Å
α=90.00° β=112.9050(10)° γ=90.00°
(<i>E</i>)-1-(4,4''-Difluoro-5'-methoxy-1,1':3',1''-terphenyl-4'-yl)-3-phenylprop-2-en-1-one
C28H20F2O2
Acta Crystallographica Section E (2011) 67, 12 o3159-o3160
a=13.9226(4)Å b=6.7977(2)Å c=22.4531(7)Å
α=90.00° β=101.8740(10)° γ=90.00°
1,2-Bis(3-phenoxybenzylidene)hydrazine
C26H20N2O2
Acta Crystallographica Section E (2012) 68, 1 o81
a=23.6271(16)Å b=11.2942(6)Å c=8.2359(7)Å
α=90.00° β=109.538(8)° γ=90.00°
3,3-Dimethyl-2-benzofuran-1(3<i>H</i>)-one
C10H10O2
Acta Crystallographica Section E (2012) 68, 1 o113
a=14.3537(9)Å b=7.0069(5)Å c=8.2605(5)Å
α=90° β=90° γ=90°
<i>N</i>-(4,6-Dimethoxypyrimidin-2-yl)-2-(3-methylphenyl)acetamide
C15H17N3O3
Acta Crystallographica Section E (2012) 68, 1 o226-o227
a=7.1536(6)Å b=8.2070(7)Å c=13.8259(10)Å
α=74.420(7)° β=86.540(6)° γ=69.186(8)°
1,2-Bis[(1,3-benzodioxol-5-yl)methylidene]hydrazine
C16H12N2O4
Acta Crystallographica Section E (2012) 68, 1 o7
a=6.1835(2)Å b=4.5970(2)Å c=23.8487(10)Å
α=90.00° β=96.080(4)° γ=90.00°
2-Amino-<i>N</i>-[3-(2-chlorobenzoyl)-5-ethylthiophen-2-yl]acetamide
C15H15ClN2O2S
Acta Crystallographica Section E (2012) 68, 2 o547-o548
a=13.9784(11)Å b=13.5565(11)Å c=8.3334(7)Å
α=90.00° β=91.2330(10)° γ=90.00°
Loperamide monohydrate
C29H33ClN2O2,H2O
Acta Crystallographica Section E (2012) 68, 2 o539-o540
a=16.7869(4)Å b=15.1506(6)Å c=20.6617(6)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-5-(2-Chlorophenyl)-7-ethyl-2-oxo-2,3-dihydro-1<i>H</i>-thieno[2,3-<i>e</i>][1,4]diazepin-4-ium 2,4,6-trinitrophenolate
C15H14ClN2OS,C6H2N3O7
Acta Crystallographica Section E (2012) 68, 2 o516-o517
a=10.5704(2)Å b=20.0667(5)Å c=11.3741(2)Å
α=90.00° β=110.6660(10)° γ=90.00°
Deferasirox
C21H15N3O4,C3H7NO
Acta Crystallographica Section E (2012) 68, 3 o792-o793
a=8.8172(8)Å b=32.669(3)Å c=7.6900(7)Å
α=90.00° β=94.901(2)° γ=90.00°
4-[Bis(4-fluorophenyl)methyl]piperazin-1-ium 2-hydroxybenzoate 2-hydroxybenzoic acid monosolvate
C17H19F2N2,C7H5O3,C7H6O3
Acta Crystallographica Section E (2012) 68, 4 o1180
a=33.157(4)Å b=10.3007(14)Å c=20.105(3)Å
α=90.00° β=124.447(2)° γ=90.00°
Triprolidinium dichloranilate--chloranilic acid--methanol--water (2/1/2/2)
C19H24N22,2(C6HCl2O4),0.5(C6H2Cl2O4),CH4O,H2O
Acta Crystallographica Section E (2012) 68, 4 o1037-o1038
a=9.1633(2)Å b=32.3720(7)Å c=12.9834(4)Å
α=90° β=106.685(3)° γ=90°
(2<i>E</i>)-1-(2,6-Dichloro-3-fluorophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
C16H11Cl2FO2
Acta Crystallographica Section E (2012) 68, 4 o1163
a=11.9035(6)Å b=10.4472(5)Å c=23.7435(12)Å
α=90.00° β=92.296(4)° γ=90.00°
(2<i>E</i>)-1-(2,6-Dichloro-3-fluorophenyl)-3-phenylprop-2-en-1-one
C15H9Cl2FO
Acta Crystallographica Section E (2012) 68, 4 o1085
a=11.3390(3)Å b=10.3896(3)Å c=11.3930(3)Å
α=90.00° β=97.0780(10)° γ=90.00°
(<i>R</i>)-Doxylaminium (<i>R</i>,<i>R</i>)-tartrate
C17H23N2O,C4H5O6
Acta Crystallographica Section E (2012) 68, 4 o1054-o1055
a=7.4419(4)Å b=18.4394(8)Å c=8.3517(4)Å
α=90.00° β=108.301(5)° γ=90.00°
Cinnarizinium 3,5-dinitrosalicylate
C26H29N2,C7H3N2O7
Acta Crystallographica Section E (2012) 68, 4 o1165-o1166
a=14.5648(3)Å b=12.9374(3)Å c=16.1619(3)Å
α=90.00° β=103.9000(10)° γ=90.00°
(<i>E</i>)-3-(2-Chlorophenyl)-1-(4,4''-difluoro-5'-methoxy-1,1':3',1''-terphenyl-4'-yl)prop-2-en-1-one
C28H19ClF2O2
Acta Crystallographica Section E (2012) 68, 5 o1538-o1539
a=14.2065(7)Å b=6.8651(3)Å c=22.4817(11)Å
α=90.00° β=101.406(2)° γ=90.00°
1-{4-[Bis(4-fluorophenyl)methyl]piperazin-1-yl}ethanone
C19H20F2N2O
Acta Crystallographica Section E (2012) 68, 7 o2237
a=10.1701(5)Å b=16.5521(5)Å c=11.1690(5)Å
α=90.0° β=114.690(5)° γ=90.0°
[2-(Biphenyl-4-yl)-1,3-thiazol-4-yl]methanol
C16H13NOS
Acta Crystallographica Section E (2012) 68, 10 o2950
a=6.05424(18)Å b=29.3096(9)Å c=7.2064(2)Å
α=90.00° β=92.668(3)° γ=90.00°
1-[Bis(4-fluorophenyl)methyl]piperazine
C17H18F2N2
Acta Crystallographica Section E (2012) 68, 9 o2817
a=12.1574(5)Å b=8.8559(2)Å c=13.8604(4)Å
α=90.00° β=93.355(3)° γ=90.00°
3,5-Bis(4-fluorophenyl)-1-(4-nitrophenyl)-4,5-dihydro-1<i>H</i>-pyrazole
C21H15F2N3O2
Acta Crystallographica Section E (2012) 68, 11 o3216-o3217
a=13.2884(13)Å b=12.7364(10)Å c=11.4656(9)Å
α=90.00° β=115.324(3)° γ=90.00°
(3-Chloropropyl)triphenylphosphonium bromide
C21H21ClP,Br
Acta Crystallographica Section E (2012) 68, 11 o3115
a=11.0708(2)Å b=10.0435(2)Å c=17.5740(4)Å
α=90.00° β=104.9730(10)° γ=90.00°
(<i>E</i>)-<i>N</i>'-(4-Methoxybenzylidene)-2-<i>m</i>-tolylacetohydrazide
C17H18N2O2
Acta Crystallographica Section E (2012) 68, 12 o3435
a=6.4961(8)Å b=9.8047(10)Å c=12.7464(13)Å
α=112.130(9)° β=95.507(10)° γ=96.601(9)°
1,1'-[2,4-Bis(3-nitrophenyl)cyclobutane-1,3-diyl]diphenylmethanone
C30H22N2O6
Acta Crystallographica Section E (2012) 68, 12 o3272-o3273
a=5.78500(10)Å b=14.7824(3)Å c=14.3589(3)Å
α=90.00° β=104.8580(10)° γ=90.00°
2-(2-Nitrophenyl)acetohydrazide
C8H9N3O3
Acta Crystallographica Section E (2012) 68, 12 o3436
a=6.6962(5)Å b=4.9388(4)Å c=13.3593(12)Å
α=90.00° β=92.361(8)° γ=90.00°
(2<i>E</i>)-3-(4-Bromophenyl)-1-(4,4''-difluoro-5'-methoxy-1,1':3',1''-terphenyl-4'-yl)prop-2-en-1-one
C28H19BrF2O2
Acta Crystallographica Section E (2012) 68, 12 o3433-o3434
a=6.9648(2)Å b=11.3616(3)Å c=14.7219(4)Å
α=95.9830(10)° β=92.6010(10)° γ=105.6760(10)°
(2<i>E</i>)-3-[4-(Benzyloxy)phenyl]-1-(2,6-dichloro-3-fluorophenyl)prop-2-en-1-one
C22H15Cl2FO2
Acta Crystallographica Section E (2012) 68, 12 o3386
a=9.1977(2)Å b=21.6887(4)Å c=11.6072(2)Å
α=90.00° β=124.6290(10)° γ=90.00°
2-(4-Methylphenyl)acetohydrazide
C9H12N2O
Acta Crystallographica Section E (2012) 68, 12 o3467
a=15.4261(16)Å b=6.2618(7)Å c=9.2073(10)Å
α=90.00° β=106.651(12)° γ=90.00°
4-Methoxy-4-methyl-6-phenyltetrahydropyrimidine-2(1<i>H</i>)-thione
C12H16N2OS
Acta Crystallographica Section E (2012) 68, 12 o3271
a=10.1894(3)Å b=14.6889(4)Å c=9.2026(2)Å
α=90.00° β=111.7190(10)° γ=90.00°